Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis.
Saved in:
| Title: | Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis. |
|---|---|
| Authors: | Alarcan, Hugo1,2 (AUTHOR), Bruno, Clément3 (AUTHOR), Emond, Patrick2,4 (AUTHOR), Raoul, Cédric5,6 (AUTHOR), Vourc'h, Patrick1,2 (AUTHOR), Corcia, Philippe2,7 (AUTHOR), Camu, William5,6 (AUTHOR), Veyrune, Jean‐Luc8 (AUTHOR), Garlanda, Cecilia9,10 (AUTHOR), Locati, Massimo10 (AUTHOR), Juntas‐Morales, Raúl11 (AUTHOR), Saker, Safaa12 (AUTHOR), Suehs, Carey13 (AUTHOR), Masseguin, Christophe14 (AUTHOR), Kirby, Janine15 (AUTHOR), Shaw, Pamela15 (AUTHOR), Malaspina, Andrea16 (AUTHOR), De Vos, John17 (AUTHOR), Al‐Chalabi, Ammar18 (AUTHOR), Leigh, P. Nigel19 (AUTHOR) |
| Source: | Annals of the New York Academy of Sciences. Jun2024, Vol. 1536 Issue 1, p82-91. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!